文献速递乳腺乳腺X线US

三维定位真空辅助活检对三维钼靶检出而二维钼靶和超声阴性的结构扭曲的初步经验

Initial Experience of Tomosynthesis-Guided Vacuum-Assisted Biopsies of Tomosynthesis-Detected (2D Mammography and Ultrasound Occult) Architectural Distortions.
PubMed 文献 · AJR Am J Roentgenol · 2018-03-23

回顾性分析34处仅三维乳腺断层摄影(DBT)检出、二维钼靶和超声均阴性的结构扭曲,行三维定位真空辅助活检(VAB),恶性阳性预测值为26%(34处中9处恶性),其中8处为浸润癌、1处为导管原位癌。作者认为三维定位VAB是可行的方法,可检出相当数量的癌,多为1级癌,但需进一步研究。

要点

  • 仅DBT检出而二维钼靶和超声阴性的结构扭曲,三维定位VAB的恶性阳性预测值为26%(34处中9处恶性)。
  • 检出恶性中8处为浸润癌、1处为导管原位癌,浸润癌平均大小7.5 mm(范围6–30 mm)。
  • 浸润癌分级为1级4/8(50%)、2级2/8(25%)、3级1/8(13%),1处分级信息不可得。

核心结论

  • 三维定位VAB是对二维钼靶和超声均阴性的结构扭曲进行取材的可行方法,为微创方法,检出了相当数量的癌,且多为1级癌;作者指出需进一步研究。

研究设计与样本

  • 回顾性综述,34处经DBT检出、二维钼靶和超声均阴性的结构扭曲,行三维定位VAB,分析恶性阳性预测值。

关键影像表现/征象

  • 结构扭曲在DBT上检出,而在二维钼靶和超声上均不可见。

诊断标准与关键数值

  • 三维定位VAB对DBT检出、二维钼靶和超声阴性结构扭曲的恶性阳性预测值为26%(34处中9处恶性)。
  • 9处恶性中8处为浸润癌、1处为导管原位癌。
  • 浸润癌分级:1级4/8(50%)、2级2/8(25%)、3级1/8(13%),1处信息不可得。
  • 浸润癌病理平均大小7.5 mm(范围6–30 mm)。

临床应用与阅片要点

  • 对二维钼靶和超声均阴性、仅DBT显示的结构扭曲,可采用三维定位VAB进行取材。

局限性

  • 原文结论指出需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: As experience and aptitude in digital breast tomosynthesis (DBT) have increased, radiologists are seeing more areas of architectural distortion (AD) on DBT images compared with standard 2D mammograms. The purpose of this study is to report our experience using tomosynthesis-guided vacuum-assisted biopsies (VABs) for ADs that were occult at 2D mammography and ultrasound and to analyze the positive predictive value for malignancy.

MATERIALS AND METHODS: We performed a retrospective review of 34 DBT-detected ADs that were occult at mammography and ultrasound.

RESULTS: We found a positive predictive value of 26% (nine malignancies in 34 lesions). Eight of the malignancies were invasive and one was ductal carcinoma in situ. The invasive cancers were grade 1 (4/8; 50%), grade 2 (2/8; 25%), or grade 3 (1/8; 13%); information about one invasive cancer was not available. The mean size of the invasive cancers at pathologic examination was 7.5 mm (range, 6-30 mm).

CONCLUSION: Tomosynthesis-guided VAB is a feasible method to sample ADs that are occult at 2D mammography and ultrasound. Tomosynthesis-guided VAB is a minimally invasive method that detected a significant number of carcinomas, most of which were grade 1 cancers. Further studies are needed.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Patel BK, Covington M, Pizzitola VJ, et al. Initial Experience of Tomosynthesis-Guided Vacuum-Assisted Biopsies of Tomosynthesis-Detected (2D Mammography and Ultrasound Occult) Architectural Distortions. AJR Am J Roentgenol. 2018. PMID: 29570367. doi:10.2214/AJR.17.18802

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。